| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $13,784,651 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UG3DE032621 | Empowering dentists to reduce opioid prescriptions to young people | 000 | 1 | NIH | 12/30/2022 | $580,179 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA053070 | Functional and Genomic Signatures of Escalated Fentanyl Use | 000 | 3 | NIH | 12/22/2022 | $591,523 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K08DK124566 | Muscle ?bone interaction and its role in diabetic bone disease of Type I diabetes | 000 | 3 | NIH | 12/13/2022 | $164,517 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG070830 | Contributions of astrocyte RelA signaling in aging-related neurodegenerative sequelae following TBI | 000 | 3 | NIH | 1/18/2023 | $665,337 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG066724 | Novel gastrocnemius muscle characteristics in peripheral artery disease patients associated with impaired functional performance | 000 | 3 | NIH | 1/19/2023 | $310,862 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES032396 | A university-community partnership to reduce exposure to disinfection byproducts in Appalachia | 000 | 3 | NIH | 11/1/2022 | $492,587 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01HL149984 | Pharmacological Mechanistic Insights into Thoracic Aortic Aneurysm | 000 | 3 | NIH | 12/20/2022 | $162,000 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK124626 | Mechanisms for activation of beige adipose tissue in humans | 000 | 3 | NIH | 11/29/2022 | $548,202 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK124626 | Mechanisms for activation of beige adipose tissue in humans | 001 | 3 | NIH | 1/9/2023 | $60,909 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01EB028792 | Perioperative Diffuse Optical Imaging of Tissue Blood Flow and Oxygenation for Optimization of Mastectomy Skin Flap Viability | 000 | 3 | NIH | 11/29/2022 | $441,364 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01EB028792 | Perioperative Diffuse Optical Imaging of Tissue Blood Flow and Oxygenation for Optimization of Mastectomy Skin Flap Viability | 001 | 3 | NIH | 1/23/2023 | $49,040 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR073906 | Epigenetic control of muscle stem cell function by PASK-Wdr5 signaling | 000 | 5 | NIH | 1/19/2023 | $302,882 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01DK116923 | Social Network Analysis and Social Support Intervention for Rural Dwelling Older Adults with T2DM | 000 | 5 | NIH | 1/4/2023 | $147,756 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES030380 | Radon on the RADAR | 000 | 4 | NIH | 12/6/2022 | $523,341 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM130349 | Functional Analysis of Programmed Genome Rearrangement | 000 | 5 | NIH | 1/10/2023 | $333,377 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UC2FD006890 | Cigar Reference Products Program | 001 | 4 | FDA | 1/19/2023 | $800,000 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS103785 | Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury | 000 | 5 | NIH | 11/30/2022 | $294,279 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI143690 | Biogenesis and Function of Streptococcus Pyogenes Cell Wall | 000 | 4 | NIH | 10/18/2022 | $382,500 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA223164 | Integrin alpha6beta4 regulation of cancer epigenetics | 000 | 5 | NIH | 12/23/2022 | $419,448 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES033767 | Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women | 000 | 2 | NIH | 11/1/2022 | $428,719 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AG081016 | Dysphagia: In Search of a Unified Definition for the Aging Population | 000 | 1 | NIH | 12/7/2022 | $49,015 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AR078447 | Magnetic nanocomplexes-induced immunomodulation for fracture healing | 000 | 2 | NIH | 1/25/2023 | $142,341 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK128033 | Mirabegron and tadalafil effectiveness for treatment of prediabetes | 000 | 2 | NIH | 11/30/2022 | $275,400 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK128033 | Mirabegron and tadalafil effectiveness for treatment of prediabetes | 001 | 2 | NIH | 1/9/2023 | $30,600 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K23MH126211 | A Precision Medicine Approach to Target Engagement for Emotion Regulation | 000 | 2 | NIH | 1/26/2023 | $168,506 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00HL145117 | Macrophage Pyroptosis in Abdominal Aortic Aneurysm | 000 | 4 | NIH | 1/12/2023 | $249,000 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K23DK128562 | Classical and Alternative Renin-Angiotensin System Dysregulation in Sepsis-Associated AKI: A Reverse Translation Approach | 000 | 2 | NIH | 12/16/2022 | $157,563 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01DK128022 | Elucidating Molecular Mechanisms Linking Fructose to Cholesterol Metabolism | 000 | 2 | NIH | 12/6/2022 | $100,543 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31AG076282 | Apolipoprotein E and immunometabolism in Alzheimer's disease | 000 | 2 | NIH | 12/20/2022 | $36,206 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL162463 | Targeting The GLP-1 Receptor As New Chronotherapy Against Nondipping Blood Pressure In Diabetes | 000 | 2 | NIH | 11/18/2022 | $35,494 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P20GM121327 | University of Kentucky Center for Cancer Metabolism | 002 | 7 | NIH | 12/23/2022 | $2,060,688 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25ES027684 | Summer Research in Environmental Health Sciences | 001 | 6 | NIH | 12/13/2022 | $135,000 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AI129382 | Autumn Immunology Conference | 000 | 5 | NIH | 11/7/2022 | $18,000 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA175105 | Targeting Translation Dependence in Colorectal Cancer Progression | 000 | 9 | NIH | 12/7/2022 | $327,038 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P42ES007380 | Nutrition and Superfund Chemical Toxicity | 001 | 25 | NIH | 1/23/2023 | $412,563 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P42ES007380 | Nutrition and Superfund Chemical Toxicity | 001 | 25 | NIH | 1/23/2023 | $962,647 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG064234 | Regulation of Microglial Activation State by a Lipid Transporter | 000 | 4 | NIH | 1/18/2023 | $374,550 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UG3DE032621 | Empowering dentists to reduce opioid prescriptions to young people | 002 | 1 | NIH | 1/23/2023 | $0 |
| | 2023 | 2023 | University Of Kentucky Research Foundation, The | 500 S Limestone 109 Kinkead Hall | Lexington | KY | 40526-0001 | FAYETTE | USA | R13OH012359 | SouthON Conference Grant | 00 | 2 | CDC | 12/15/2022 | $20,000 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG080589 | APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease | 000 | 1 | NIH | 11/23/2022 | $642,417 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K99CA277245 | Reducing Lung Cancer Risk among Appalachian Women Using Community?Engaged Intervention Research | 000 | 1 | NIH | 1/12/2023 | $104,289 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI176298 | A Randomized Clinical Trial of Continuous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury Biomarkers | 000 | 1 | NIH | 1/20/2023 | $249,623 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI169231 | Function of the type 7 secretion system in Group B Streptococcus | 000 | 1 | NIH | 11/7/2022 | $247,918 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21HL166178 | Precise in vivo gene editing of HSPC for the treatment of genetic hematologic diseases | 000 | 1 | NIH | 12/20/2022 | $229,500 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI173735 | Addressing genetic tractability and species-specific infection biology in Chlamydia pneumoniae | 000 | 1 | NIH | 11/7/2022 | $229,500 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UG3DE032621 | Empowering dentists to reduce opioid prescriptions to young people | 001 | 1 | NIH | 1/5/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL166225 | Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis | 000 | 1 | NIH | 12/13/2022 | $664,969 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA053070 | Functional and Genomic Signatures of Escalated Fentanyl Use | 001 | 3 | NIH | 1/25/2023 | $65,724 |
| | 2023 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA221867 | Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy | 000 | 6 | NIH | 11/16/2022 | $505,692 |
|
